1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/39904
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLow M.en
dc.contributor.authorTarlinton D.en
dc.contributor.authorGrigoriadis G.en
dc.contributor.authorInfantino S.en
dc.date.accessioned2021-05-14T13:38:35Zen
dc.date.available2021-05-14T13:38:35Zen
dc.date.copyright2016en
dc.date.created20160225en
dc.date.issued2016-02-25en
dc.identifier.citationImmunological Reviews. 270 (1) (pp 78-94), 2016. Date of Publication: 01 Mar 2016.en
dc.identifier.issn0105-2896en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/39904en
dc.description.abstractAntibody-secreting cells (ASCs) are critical for a functional and effective adaptive immune system. In a number of illnesses, however, these same cells contribute to the underlying disease state leading to significant morbidity and mortality. While therapeutic targeting of antibody-secreting cells has progressed significantly over the last two decades, many of these conditions remain major health problems. In this review, we will discuss current and potential therapeutic targeting of ASCs in the context of the known biology of these cells.Copyright © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.en
dc.languageEnglishen
dc.languageenen
dc.publisherBlackwell Publishing Ltd (E-mail: customerservices@oxonblackwellpublishing.com)en
dc.relation.ispartofImmunological Reviewsen
dc.titleTargeting plasma cells: Are we any closer to a panacea for diseases of antibody-secreting cells?.en
dc.typeReviewen
dc.type.studyortrialReview article (e.g. literature review, narrative review)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/imr.12388en
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid26864106 [http://www.ncbi.nlm.nih.gov/pubmed/?term=26864106]en
dc.identifier.source608273971en
dc.identifier.institution(Low, Infantino, Tarlinton) Immunology Division, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC, Australia (Low, Grigoriadis, Tarlinton) Department of Haematology, Monash Health, Monash Hospital, Clayton, VIC, Australia (Low, Infantino) Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia (Grigoriadis) School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia (Grigoriadis) Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia (Grigoriadis) Malignant Haematology and Stem Cell Transplantation Service and Alfred Pathology Service, The Alfred, Melbourne, VIC, Australiaen
dc.description.addressD. Tarlinton, Department of Immunology and Pathology, Monash University, 89 Commercial Road, Prahran, VIC 3181, Australia. E-mail: david.tarlinton@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2017 Elsevier B.V., All rights reserved.en
dc.subect.keywordsAntibody-secreting cells Plasma cells Therapeuticsen
dc.identifier.authoremailTarlinton D.; david.tarlinton@monash.eduen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeReview-
crisitem.author.deptHaematology-
crisitem.author.deptHaematology-
Appears in Collections:Articles
Show simple item record

Page view(s)

26
checked on Feb 7, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.